Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 482 of 1,261
  1. US 10369225

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  2. US 10369232

    Allele selective gene editing and uses thereof

    ARCTURUS THERAPEUTICS, INC. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  3. US 10369208

    Methods for the induction of immune responses in a subject compromising administering virus-like particles (VLPS) prepared from Chikungunya virus structural proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  4. US 10369192

    Methods and compositions for delivery of exogenous factors to nervous system sites

    REGENERATIVE RESEARCH FOUNDATION · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  5. US 10369182

    Compositions and methods for treating insomnia and other sleep related disorders

    Script Essentials, LLC · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  6. US 10369184

    Composition and use thereof in manufacture of product for improving intestinal function

    INFINITUS (CHINA) COMPANY LTD. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  7. US 10369195

    Methods and compositions for preventing and treating damage to the heart

    The Regents of the University of California · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  8. US 10369145

    Coumarin derivatives and methods of use in treating hyperproliferative diseases

    DISCOVERYBIOMED, INC. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  9. US 10369142

    Combination dosage form of a mu opioid receptor antagonist and an opioid agent

    Theravance Biopharma R&D IP, LLC · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  10. US 10369148

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  11. US 10369118

    Method of reducing scarring

    Cole Research & Design, LLC · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  12. US 10369131

    Ultrapure tetrahydrocannabinol-11-oic acids

    Corbus Pharmaceuticals, Inc. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  13. US 10369106

    Efficient aqueous encapsulation and controlled release of bioactive agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  14. US 10369103

    Neuroprotective liposome compositions and methods for treatment of stroke

    The Board of Regents of the University of Texas System · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  15. US 10368569

    Natural sweetener

    MONTERO GIDA SANAYI VE TICARET A.S. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  16. US 10368543

    Pest control using natural pest control agent blends

    TYRATECH, INC. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  17. US 10369098

    Methods for localized drug delivery

    Compass Therapeutics LLC · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  18. US 10370680

    Method of treating factor IX deficiency using nuclease-mediated targeted integration

    Sangamo Therapeutics, Inc. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  19. US 10370666

    Ketohexokinase (KHK) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  20. US 10370659

    Compounds and methods for increasing antisense activity

    Ionis Pharmaceuticals, Inc. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  21. US 10370661

    Nucleic acid functionalized nanoparticles for therapeutic applications

    Northwestern University · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  22. US 10370656

    Nucleic acid functionalized nanoparticles for therapeutic applications

    Northwestern University · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  23. US 10370488

    Stimulus-responsive poly(lactic-co-glycolic)-based polymers and nanoparticles formed therefrom

    The Regents of the University of California · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  24. US 10370439

    Prevention of tissue ischemia and related methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.